Tan, Miraflora .
HRN: 22-51-40 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2023
CEFUROXIME 1.5GM (VIAL)
06/19/2023
06/26/2023
IV
1.5 G
Q8 X 3 Doses
SP TAH Witb Enterolysis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes